Neumora Therapeutics OverviewNeumora Therapeutics Net Income
Profitability analysis for NMRA.
Quarterly Net Income
-$53.46M
↑ 21.38% YoY
As of Mar 2026
Annual Net Income (TTM)
-$222.39M
↑ 13.82% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...